|
Index of reports
> Cases with Thrombocytopenia (125)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 125 Next >>
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Carboplatin side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Pemetrexed Disodium
Dosage: 200 df, unknown/d
Indication: non-Small Cell Lung Cancer
Start date: 2012-08-03
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-08-17
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Weight Decreased, Escherichia Test Positive, Malaise, Vomiting, Nausea, Dysuria, Clostridium Difficile Colitis, Culture Urine Positive, Thrombocytopenia, Enterobacter Test Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxol
Dosage: 299 mg
Carboplatin
Dosage: 376 mg
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-08-23
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Placebo
Indication: Breast Cancer
Start date: 2012-04-25
Docetaxel
Indication: Breast Cancer
Start date: 2012-04-25
Herceptin
Indication: Breast Cancer
Start date: 2012-04-25
Herceptin
Carboplatin
Dosage: 5 auc
Indication: Breast Cancer
Start date: 2012-04-25
Other drugs received by patient: Metoprolol Tartrate
Possible Carboplatin side effects in male
Reported by a physician from Hungary on 2012-08-22
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Pneumonia, Anaemia, Granulocytopenia, Neutropenia, Thrombocytopenia, Leukopenia, Infectious Pleural Effusion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Dosage: last dose prior to sae: 01 april 2010
Carboplatin
Dosage: last dose prior to event on 25 january 2010.
Gemcitabine Hydrochloride
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Carboplatin
Dosage: form: infusion;
Indication: non-Small Cell Lung Cancer
Carboplatin
Dosage: last dose prior to sae: 23 march 2010, frequency: 1xdaily
Avastin
Dosage: frequency: 1x, form infusion;
Indication: non-Small Cell Lung Cancer
Gemcitabine Hydrochloride
Dosage: last dose of iv gemcitabine prior to event on 25 january 2010.
Avastin
Dosage: frequency as per protocol, last dose of prior to event on 25 january 2010. form infusion
Gemcitabine Hydrochloride
Dosage: freq: day 1 + 8 every 3 weeks
Avastin
Dosage: last dose prior to sae: 16 february 2010. last dose prior to leukopenia was 23 mar 2010
Gemcitabine Hydrochloride
Dosage: form infusion, on day 1 and day 8; frequency: 1xdaily;
Indication: non-Small Cell Lung Cancer
Start date: 2009-11-09
End date: 2009-11-17
Gemcitabine Hydrochloride
Dosage: frequency: 2xevery three week, form: infusion
Carboplatin
Avastin
Dosage: last dose prior to sae: 16 february 2010,infusion, frequency: 1xdaily
Other drugs received by patient: Fluticasone Propionate / Salmeterol; Augmentin '500'; Kalium-R; Sinecod; Ondansetron; Bisoprolol Fumarate; Pegfilgrastim; Lidocaine; Ciprofloxacin Hydrochloride; Neupogen; Spiriva; Kalium-R; Eprex; Neorecormon; Hydromorphone HCL; Berodual; Fluticasone Propionate / Salmeterol; Neorecormon; Augmentin '500'; Kalium-R; Medrol; Medrol; Neupogen; Medrol; Bisoprolol Fumarate; Spiriva; Megesin; Megesin
Possible Carboplatin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: 44 year old female
Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: maintenance dose for a total cumulative dose of 1.696 mg
Indication: Ovarian Cancer
End date: 2010-04-01
Carboplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Topotecan Hydrochloride
Start date: 2005-08-29
Cisplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-10
Topotecan Hydrochloride
Dosage: for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-02
Doxorubicin Hydrochloride
Dosage: 3 cycles given
Start date: 2007-07-13
End date: 2007-09-14
ABT-888
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Cyclophosphamide
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Paclitaxel
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Possible Carboplatin side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-14
Patient: 72 year old male
Reactions: Pneumonia, Hypotension, Febrile Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Etoposide
Dosage: 50 mg/m2 on day1 and 3
Indication: Small Cell Lung Cancer Stage Unspecified
Carboplatin
Dosage: 300 mg/m2 on day1
Indication: Small Cell Lung Cancer Stage Unspecified
Possible Carboplatin side effects in 71 year old male
Reported by a physician from Japan on 2012-08-14
Patient: 71 year old male, weighing 45.0 kg (99.0 pounds)
Reactions: Haemoglobin Decreased, Diarrhoea, Febrile Neutropenia, Gastroenteritis Staphylococcal, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Irinotecan Hydrochloride
Dosage: 70 mg, single
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2011-12-21
End date: 2011-12-21
Irinotecan Hydrochloride
Dosage: 60 mg, single
Start date: 2012-03-06
End date: 2012-03-06
Carboplatin
Dosage: 220 mg, single
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2011-12-21
End date: 2011-12-21
Irinotecan Hydrochloride
Dosage: 60 mg, single
Start date: 2012-02-28
End date: 2012-02-28
Carboplatin
Dosage: 210 mg, single
Start date: 2012-02-28
End date: 2012-02-28
Carboplatin
Dosage: 220 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2011-12-28
End date: 2011-12-28
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2012-01-20
End date: 2012-01-20
Irinotecan Hydrochloride
Dosage: 70 mg, single
Start date: 2012-01-27
End date: 2012-01-27
Other drugs received by patient: NEU-UP; Ambisome; Lansoprazole; Decadron Phosphate; Vancomycin Hydrochloride; Zyvox; Kremezin; Platelets, Human Blood; Allopurinol; Maxipime; Loperamide Hydrochloride; Itraconazole; Targocid; Meropenem; BIO Three; Gran; Medrol
Possible Carboplatin side effects in
Reported by a physician from United States on 2012-08-13
Patient:
Reactions: Thrombosis, Pneumonia, Haemorrhage, Anaemia, Procedural Site Reaction, Ulcer Haemorrhage, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 812 mg
End date: 2012-07-10
Fluorouracil
Dosage: 7160 mg
End date: 2012-07-14
Possible Carboplatin side effects in 72 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-08
Patient: 72 year old male
Reactions: Pneumonia, Hypotension, Febrile Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 300 mg/m2, on day 1
Indication: Small Cell Lung Cancer Stage Unspecified
Etoposide
Dosage: 50 mg/m2, on days 1 and 3
Indication: Small Cell Lung Cancer Stage Unspecified
Possible Carboplatin side effects in 72 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-03
Patient: 72 year old male
Reactions: Pneumonia, Neoplasm Malignant, Hypotension, Febrile Neutropenia, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: on day1 + 3
Indication: Small Cell Lung Cancer Stage Unspecified
Carboplatin
Dosage: on day1
Indication: Small Cell Lung Cancer Stage Unspecified
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient: female
Reactions: Hypophosphataemia, Fatigue, Tinnitus, Clostridium Difficile Colitis, Neutropenia, Thrombocytopenia, Klebsiella Bacteraemia
Drug(s) suspected as cause:
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Ovarian Cancer
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Malignant Peritoneal Neoplasm
Carboplatin
Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
Indication: Ovarian Cancer
Paclitaxel
Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
Indication: Fallopian Tube Cancer
Paclitaxel
Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
Indication: Ovarian Cancer
Possible Carboplatin side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17
Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Hypotension, Disseminated Intravascular Coagulation, Headache, Malaise, Sepsis, Neutropenia, Cardiac Arrest, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carboplatin
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-04
Etoposide
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-06
Other drugs received by patient: Aldactone; Urief; Warfarin Sodium; Alendronate Sodium; Spiriva; Magnesium Oxide; Theophylline; Ambroxol Hydrochloride; Enalapril Maleate; Seltepnon; Vasolator; Sotalol Hydrochloride
Possible Carboplatin side effects in 64 year old female
Reported by a physician from France on 2012-07-16
Patient: 64 year old female, weighing 54.0 kg (118.8 pounds)
Reactions: Muscle Atrophy, Neutropenia, Polyarthritis, Thrombocytopenia, Paraesthesia
Drug(s) suspected as cause:
Taxotere
Dosage: dose: 4 cycles at 120 mg every 3 weeks
Indication: Bronchial Carcinoma
Start date: 2011-03-28
End date: 2011-06-03
Carboplatin
Indication: Bronchial Carcinoma
End date: 2011-06-01
Possible Carboplatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-13
Patient: male
Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from Italy on 2012-07-11
Patient: male
Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in female
Reported by a consumer/non-health professional from Italy on 2012-06-27
Patient: female
Reactions: Respiratory Failure, Neutropenia, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18
Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Malaise, Hypotension, Disseminated Intravascular Coagulation, Neutropenia, Headache, Thrombocytopenia, Cardiac Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-06
Carboplatin
Dosage: dose unit: unknown
Indication: Small Cell Lung Cancer Stage Unspecified
Start date: 2010-10-04
End date: 2010-10-04
Other drugs received by patient: Sotalol Hydrochloride; Ambroxol Hydrochloride; Seltepnon; Enalapril Maleate; Magnesium Oxide; Carvedilol; Alendronate Sodium; Spiriva; Furosemide; Warfarin Sodium; Theophylline; Aldactone; Urief; Vasolator
Possible Carboplatin side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-18
Patient:
Reactions: Thrombosis, Confusional State, Pain, Fatigue, Thrombocytopenia, Decreased Appetite, Arterial Thrombosis, Vomiting, Dyspnoea, Nausea, Lymphopenia, Anaemia, Hyponatraemia, Pulmonary Haemorrhage, Diarrhoea, Dehydration, Neutropenia, Hypertension, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: auc 6
Indication: non-Small Cell Lung Cancer
Bortezomib and Bortezomib
Dosage: 1.3, 1.6 and 1.8 mg/square meter weekly on day 1 and day 8 of every 3 week cycle
Indication: non-Small Cell Lung Cancer
Avastin
Indication: non-Small Cell Lung Cancer
Possible Carboplatin side effects in male
Reported by a physician from Italy on 2012-06-14
Patient: male
Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Drug(s) suspected as cause:
Carmustine
Indication: Burkitt's Lymphoma
Carboplatin
Indication: Burkitt's Lymphoma
Rituximab
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Melphalan Hydrochloride
Indication: Burkitt's Lymphoma
Radiotherapy
Indication: Burkitt's Lymphoma
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cisplatin
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Granulocyte Colony Stimulating Factor
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Burkitt's Lymphoma
Unknown Medication
Dosage: antimicrobial prophylaxis
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-06-13
Patient: male, weighing 85.3 kg (187.7 pounds)
Reactions: Respiratory Failure, Sepsis, Thrombocytopenia, Renal Failure Acute, Leukopenia, Infectious Peritonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 df, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Pemetrexed Disodium
Dosage: 500 mg/m2, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Avastin
Dosage: 15 mg/m2, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2009-09-04
End date: 2009-09-04
Other drugs received by patient: Folic Acid; Duragesic-100; Vitamin B-12; Megestrol Acetate; Dexamethasone; Nexium; Fluconazole; Norco
Possible Carboplatin side effects in female
Reported by a physician from Korea, Republic of on 2012-06-12
Patient: female
Reactions: Stomatitis, Vomiting, Gastrointestinal Haemorrhage, Nausea, Alanine Aminotransferase Increased, Anaemia, Febrile Neutropenia, Impaired Healing, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Avastin
Indication: Breast Cancer
Docetaxel
Indication: Breast Cancer
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-06-07
Patient: female, weighing 150.6 kg (331.2 pounds)
Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Taxol
Dosage: 80 mg/m2, unk
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Afinitor
Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-21
End date: 2012-05-25
Bevacizumab
Dosage: 10 mg/kg, qd
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-06-07
Patient: female, weighing 150.6 kg (331.2 pounds)
Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, qd
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Afinitor
Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-21
End date: 2012-05-25
Taxol
Dosage: 80 mg/m2, unk
Indication: Metastatic Malignant Melanoma
Start date: 2012-05-18
End date: 2012-05-18
Carboplatin
Possible Carboplatin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-05
Patient: female
Reactions: Vomiting, Wound Dehiscence, Nausea, Pain, Hyperglycaemia, Proteinuria, Ejection Fraction Decreased, Neutropenia, Hypertension, Blood Creatinine Increased, Thrombocytopenia, Infection
Drug(s) suspected as cause:
Herceptin
Dosage: for 23 weeks
Avastin
Dosage: for 23 weeks
Indication: Breast Cancer
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: total 54 weeks
Paclitaxel
Dosage: days 1, 8 and 15
Indication: Breast Cancer
Avastin
Dosage: total 54 weeks
Carboplatin
Dosage: auc=6 for 6 cycles
Indication: Breast Cancer
Possible Carboplatin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05
Patient: 44 year old female
Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: maintenance dose for a total cumulative dose of 1.696 mg
Indication: Ovarian Cancer
End date: 2010-04-01
Topotecan
Start date: 2005-08-29
Doxorubicin HCL
Dosage: 3 cycles given
Start date: 2007-07-13
End date: 2007-09-14
Paclitaxel
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
ABT-888
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Topotecan
Dosage: for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-02
Cyclophosphamide
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Carboplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Cisplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-10
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-05
Patient: female
Reactions: Confusional State, Respiratory Failure, Hyponatraemia, Neutropenia, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in 67 year old male
Reported by a consumer/non-health professional from United States on 2012-06-01
Patient: 67 year old male, weighing 155.0 kg (341.0 pounds)
Reactions: Syncope, Anaemia, Dehydration, Haematuria, Thrombocytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df=2.25auc last dose on 27mar2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-23
Pemetrexed Disodium
Dosage: 23jan12-12feb12,5mar02-5mar2012(3654d) 188mg/m2:27mar2012
Indication: non-Small Cell Lung Cancer
Start date: 2002-03-05
Other drugs received by patient: Folic Acid; Triamterene; Metoprolol Tartrate; Potassium Chloride; Calcium Carbonate; Decadron; Mirtazapine; Vitamin B-12; Magnesium Oxide; Neulasta; Denosumab
Possible Carboplatin side effects in male
Reported by a physician from Italy on 2012-05-31
Patient: male
Reactions: Mucosal Inflammation, Pneumonia, Bone Marrow Failure, Pyrexia, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ifosfamide
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2011-11-23
End date: 2011-11-25
Carboplatin
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2011-11-23
End date: 2011-11-25
Etoposide
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2011-11-23
End date: 2011-11-25
Mabthera
Indication: non-Hodgkin's Lymphoma Recurrent
Start date: 2011-11-28
End date: 2011-11-28
Other drugs received by patient: Mesna; Mycostatin; Acetaminophen; Chlorpheniramine TAB; Allopurinol; Ondansetron; Neulasta
Possible Carboplatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-29
Patient: female
Reactions: Respiratory Failure, Hyponatraemia, Disorientation, Neutropenia, Thrombocytopenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Page 1 Next >>
|
